Cargando…
Rationale and design of the myocardial microinjury and cardiac remodeling extension study in the sodium lowering in dialysate trial (Mac-SoLID study)
BACKGROUND: The Sodium Lowering in Dialysate (SoLID) trial is an ongoing a multi-center, prospective, randomised, single-blind (assessor), controlled, parallel assignment clinical trial, enrolling 96 home and self-care hemodialysis (HD) patients from 7 centers in New Zealand. The trial will evaluate...
Autores principales: | Dunlop, Joanna Leigh, Vandal, Alain Charles, de Zoysa, Janak Rashme, Gabriel, Ruvin Sampath, Gerber, Lukas Mathias, Haloob, Imad Adbi, Hood, Christopher John, Irvine, John Hamilton, Matheson, Philip James, McGregor, David Owen Ross, Rabindranath, Kannaiyan Samuel, Schollum, John Benedict William, Semple, David John, Marshall, Mark Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114800/ https://www.ncbi.nlm.nih.gov/pubmed/25047825 http://dx.doi.org/10.1186/1471-2369-15-120 |
Ejemplares similares
-
Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
por: Dunlop, Joanna Leigh, et al.
Publicado: (2013) -
Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass
por: Dunlop, Joanna Leigh, et al.
Publicado: (2015) -
Laser-induced microinjury of the corneal basal epithelium and imaging of resident macrophage responses in a live, whole-eye preparation
por: Gulka, Sebastian M. D., et al.
Publicado: (2023) -
Pot/Lid Illusion
por: Mastandrea, Stefano, et al.
Publicado: (2016) -
To dialyse or delay: a qualitative study of older New Zealanders’ perceptions and experiences of decision-making, with stage 5 chronic kidney disease
por: Lovell, Sarah, et al.
Publicado: (2017)